Joseph J. Chow serves as Chairman of the Board, Chief Executive Officer of the Company. Mr. Chow has been a member of our board of directors since November 3, 2014, the Chairman of our board of directors since February 3, 2019, our acting CEO between May 10, 2019 and August 5, 2019 and our CEO since August 5, 2019. Mr. Chow has over 20 years of experience in corporate finance, financial advisory and management and has held senior executive and managerial positions in various public and private companies. Prior to August 2019, Mr. Chow served as a managing director of Centurium Capital. Previously Mr. Chow was a managing director of Moelis and Company and a managing director at Goldman Sachs (Asia) LLP. Prior to that, he served as an independent financial consultant, as chief financial officer of Harbor Networks Limited, and as chief financial officer of China Netcom (Holdings) Company Limited. Prior to that, Mr. Chow served as the director of strategic planning of Bombardier Capital, Inc., as vice president of international operations of Citigroup and as the corporate auditor of GE Capital. Mr. Chow is currently an independent non-executive director for China ZhongDi Dairy Holdings Company Limited. Mr. Chow obtained a Bachelor of Arts degree in political science from Nanjing Institute of International Relations and a Master of Business Administration degree from the University of Maryland at College Park. Mr. Chow is a Class I director.
Joseph Chow is 57, he's been the Chairman of the Board und Chief Executive Officer of China Biologic Products Inc since 2019. There are 1 older and 4 younger executives at China Biologic Products Inc. The oldest executive at China Biologic Products Holdings Inc is Xiaosheng Shao, 63, who is the Independent Director.
Joseph's mailing address filed with the SEC is 18TH FLOOR, JIALONG INTERNATIONAL, BUILDING, 19 CHAOYANG PARK ROAD, BEIJING, F4, 100125.
Over the last 17 years, insiders at China Biologic Products Inc have traded over $4,633,340,868 worth of China Biologic Products Inc stock and bought 6,331,200 units worth $103,519,340 . The most active insiders traders include Pincus Private Equity X, L...., X Biologics Llc Warburg Pin... und X Biologics Llckaye Charles.... On average, China Biologic Products Inc executives and independent directors trade stock every 38 days with the average trade being worth of $126,850,084. The most recent stock trade was executed by Zhijing Cbpo Liu on 8 May 2017, trading 7,500 units of CBPO stock currently worth $73,875.
China Biologic Products Inc executives and other stock owners filed with the SEC include: